Amylyx Pharmaceuticals Inc (AMLX)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-04-02 | 2025-03-31 | S Sale |
Chief Financial Officer Officer |
10,896
-3.6%
3.47USD 37,806 |
10,896 -3.6% | 3.47 | USD 37,806 | |
| 2025-04-02 | 2025-03-31 | S Sale |
Chief Legal Officer Officer |
9,192
-4.7%
3.48USD 31,954 |
9,192 -4.7% | 3.48 | USD 31,954 | |
| 2025-04-02 | 2025-03-31 | S Sale |
Chief Medical Officer Officer |
12,425
-6.0%
3.47USD 43,082 |
12,425 -6.0% | 3.47 | USD 43,082 | |
| 2025-04-02 | 2025-03-31 | S Sale |
Co-Chief Executive Officer Executive Director |
21,490
-0.6%
3.46USD 74,454 |
21,490 -0.6% | 3.46 | USD 74,454 | |
| 2025-04-02 | 2025-03-31 | S Sale |
Co-Chief Executive Officer Executive Director |
21,490
-0.6%
3.47USD 74,482 |
21,490 -0.6% | 3.47 | USD 74,482 | |
| 2025-03-24 | 2025-03-20 | B Purchase | Non-Executive Director |
10,000
+inf%
3.70USD 37,005 |
10,000 +inf% | 3.70 | USD 37,005 | |
| 2025-03-05 | 2025-03-03 | S Sale |
Co-Chief Executive Officer Executive Director |
4,595
-0.1%
3.17USD 14,549 |
4,595 -0.1% | 3.17 | USD 14,549 | |
| 2025-03-05 | 2025-03-03 | S Sale |
Co-Chief Executive Officer Executive Director |
4,595
-0.1%
3.15USD 14,483 |
4,595 -0.1% | 3.15 | USD 14,483 | |
| 2025-03-05 | 2025-03-03 | S Sale |
Chief Legal Officer Officer |
1,611
-1.2%
3.12USD 5,022 |
1,611 -1.2% | 3.12 | USD 5,022 | |
| 2025-02-26 | 2025-02-24 | S Sale |
Chief Legal Officer Officer |
4,169
-3.0%
3.15USD 13,145 |
4,169 -3.0% | 3.15 | USD 13,145 | |
| 2025-02-05 | 2025-02-03 | S Sale |
Co-Chief Executive Officer Executive Director |
11,855
-0.4%
3.47USD 41,104 |
11,855 -0.4% | 3.47 | USD 41,104 | |
| 2025-02-05 | 2025-02-03 | S Sale |
Co-Chief Executive Officer Executive Director |
11,851
-0.4%
3.47USD 41,108 |
11,851 -0.4% | 3.47 | USD 41,108 | |
| 2025-02-05 | 2025-02-03 | S Sale |
Chief Legal Officer Officer |
3,678
-2.6%
3.49USD 12,839 |
3,678 -2.6% | 3.49 | USD 12,839 | |
| 2025-01-08 | 2025-01-06 | S Sale |
Co-Chief Executive Officer Executive Director |
7,471
-0.2%
4.04USD 30,202 |
7,471 -0.2% | 4.04 | USD 30,202 | |
| 2025-01-08 | 2025-01-06 | S Sale |
Co-Chief Executive Officer Executive Director |
7,471
-0.2%
4.05USD 30,232 |
7,471 -0.2% | 4.05 | USD 30,232 | |
| 2024-12-03 | 2024-12-02 | S Sale |
Chief Medical Officer Officer |
5,421
-3.8%
5.54USD 30,007 |
5,421 -3.8% | 5.54 | USD 30,007 | |
| 2024-10-02 | 2024-09-30 | S Sale |
Chief Legal Officer Officer |
8,709
-5.7%
3.20USD 27,840 |
8,709 -5.7% | 3.20 | USD 27,840 | |
| 2024-10-02 | 2024-09-30 | S Sale |
Chief Medical Officer Officer |
11,442
-7.4%
3.20USD 36,559 |
11,442 -7.4% | 3.20 | USD 36,559 | |
| 2024-10-02 | 2024-09-30 | S Sale |
Co-Chief Executive Officer Executive Director |
18,589
-0.6%
3.20USD 59,429 |
18,589 -0.6% | 3.20 | USD 59,429 | |
| 2024-10-02 | 2024-09-30 | S Sale |
Co-Chief Executive Officer Executive Director |
18,589
-0.6%
3.20USD 59,414 |
18,589 -0.6% | 3.20 | USD 59,414 | |
| 2024-09-16 | 2024-09-12 | B Purchase |
Chief Financial Officer Officer |
40,000
+20.7%
2.53USD 101,368 |
40,000 +20.7% | 2.53 | USD 101,368 | |
| 2024-09-09 | 2024-09-05 | B Purchase | Non-Executive Director |
50,000
+1000.0%
2.13USD 106,590 |
50,000 +1000.0% | 2.13 | USD 106,590 | |
| 2024-09-05 | 2024-09-03 | B Purchase | Non-Executive Director |
100,000
+13.2%
2.20USD 219,800 |
100,000 +13.2% | 2.20 | USD 219,800 | |
| 2024-05-16 | 2024-05-15 | PS Planned sale |
Chief Legal Officer Officer |
10,455
-6.5%
1.88USD 19,654 |
10,455 -6.5% | 1.88 | USD 19,654 | |
| 2024-05-16 | 2024-05-15 | B Purchase | Non-Executive Director |
2,250
+81.8%
1.89USD 4,252 |
2,250 +81.8% | 1.89 | USD 4,252 | |
| 2024-05-16 | 2024-05-14 | B Purchase | Non-Executive Director |
2,750
+inf%
1.89USD 5,184 |
2,750 +inf% | 1.89 | USD 5,184 | |
| 2024-03-07 | 2024-03-05 | S Sale |
Chief Financial Officer Officer |
1,792
-1.3%
18.73USD 33,560 |
1,792 -1.3% | 18.73 | USD 33,560 | |
| 2024-03-07 | 2024-03-05 | S Sale |
Co-Chief Executive Officer Executive Director |
4,135
-0.1%
18.73USD 77,440 |
4,135 -0.1% | 18.73 | USD 77,440 | |
| 2024-03-07 | 2024-03-05 | S Sale |
Co-Chief Executive Officer Executive Director |
4,135
-0.1%
18.73USD 77,440 |
4,135 -0.1% | 18.73 | USD 77,440 | |
| 2024-03-07 | 2024-03-05 | S Sale |
Chief Legal Officer Officer |
1,540
-1.9%
18.73USD 28,841 |
1,540 -1.9% | 18.73 | USD 28,841 | |
| 2024-02-27 | 2024-02-23 | S Sale |
Chief Legal Officer Officer |
2,838
-5.8%
18.76USD 53,231 |
2,838 -5.8% | 18.76 | USD 53,231 | |
| 2024-01-11 | 2024-01-09 | S Sale |
Chief Medical Officer Officer |
2,812
-1.3%
16.33USD 45,915 |
2,812 -1.3% | 16.33 | USD 45,915 | |
| 2024-01-11 | 2024-01-09 | S Sale |
Co-Chief Executive Officer Executive Director |
5,841
-0.2%
16.33USD 95,372 |
5,841 -0.2% | 16.33 | USD 95,372 | |
| 2024-01-11 | 2024-01-09 | S Sale |
Chief Financial Officer Officer |
2,716
-2.4%
16.33USD 44,347 |
2,716 -2.4% | 16.33 | USD 44,347 | |
| 2024-01-11 | 2024-01-09 | S Sale |
Co-Chief Executive Officer Executive Director |
5,841
-0.2%
16.33USD 95,372 |
5,841 -0.2% | 16.33 | USD 95,372 | |
| 2023-12-19 | 2023-12-15 | B Purchase | Non-Executive Director |
4,000
+400.0%
14.97USD 59,880 |
4,000 +400.0% | 14.97 | USD 59,880 | |
| 2023-08-17 | 2023-08-15 | PS Planned sale |
Chief Legal Officer Officer |
6,164
-11.2%
20.88USD 128,686 |
6,164 -11.2% | 20.88 | USD 128,686 | |
| 2023-05-18 | 2023-05-16 | PS Planned sale |
Chief Financial Officer Officer |
500
-0.9%
27.60USD 13,800 |
500 -0.9% | 27.60 | USD 13,800 | |
| 2023-05-18 | 2023-05-16 | PS Planned sale |
Chief Financial Officer Officer |
32,000
-36.3%
26.93USD 861,651 |
32,000 -36.3% | 26.93 | USD 861,651 | |
| 2023-05-17 | 2023-05-15 | PS Planned sale |
Chief Medical Officer Officer |
11,965
-5.4%
29.03USD 347,358 |
11,965 -5.4% | 29.03 | USD 347,358 | |
| 2023-04-19 | 2023-04-17 | PS Planned sale |
Chief Medical Officer Officer |
300
-0.1%
30.94USD 9,282 |
300 -0.1% | 30.94 | USD 9,282 | |
| 2023-04-19 | 2023-04-17 | PS Planned sale |
Chief Medical Officer Officer |
49,279
-19.1%
30.53USD 1,504,660 |
49,279 -19.1% | 30.53 | USD 1,504,660 | |
| 2023-03-29 | 2023-03-28 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
100,000
-1.4%
30.37USD 3,037,000 |
100,000 -1.4% | 30.37 | USD 3,037,000 | |
| 2023-03-29 | 2023-03-27 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
28,000
-0.4%
30.80USD 862,400 |
28,000 -0.4% | 30.80 | USD 862,400 | |
| 2023-03-29 | 2023-03-27 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
32,964
-0.5%
30.25USD 997,161 |
32,964 -0.5% | 30.25 | USD 997,161 | |
| 2023-03-23 | 2023-03-21 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
28,807
-0.4%
32.17USD 926,721 |
28,807 -0.4% | 32.17 | USD 926,721 | |
| 2023-03-23 | 2023-03-21 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
34,641
-0.5%
31.69USD 1,097,773 |
34,641 -0.5% | 31.69 | USD 1,097,773 | |
| 2023-03-20 | 2023-03-16 | PS Planned sale |
Chief Medical Officer Officer |
2,416
-1.6%
32.43USD 78,358 |
2,416 -1.6% | 32.43 | USD 78,358 | |
| 2023-03-20 | 2023-03-16 | PS Planned sale |
Chief Medical Officer Officer |
52,211
-25.6%
31.85USD 1,662,842 |
52,211 -25.6% | 31.85 | USD 1,662,842 | |
| 2023-03-20 | 2023-03-16 | PS Planned sale | Non-Executive Director |
1,916
-0.2%
32.45USD 62,172 |
1,916 -0.2% | 32.45 | USD 62,172 | |
| 2023-03-20 | 2023-03-16 | PS Planned sale | Non-Executive Director |
33,084
-3.7%
31.86USD 1,053,901 |
33,084 -3.7% | 31.86 | USD 1,053,901 | |
| 2023-03-20 | 2023-03-16 | PS Planned sale |
Co-Chief Executive Officer Executive Director |
3,445
-0.1%
32.48USD 111,877 |
3,445 -0.1% | 32.48 | USD 111,877 | |
| 2023-03-20 | 2023-03-16 | PS Planned sale |
Co-Chief Executive Officer Executive Director |
96,555
-3.3%
31.84USD 3,074,359 |
96,555 -3.3% | 31.84 | USD 3,074,359 | |
| 2023-03-20 | 2023-03-16 | PS Planned sale |
Chief Financial Officer Officer |
1,704
-53.0%
32.46USD 55,320 |
1,704 -53.0% | 32.46 | USD 55,320 | |
| 2023-03-20 | 2023-03-16 | PS Planned sale |
Chief Financial Officer Officer |
30,796
-90.6%
31.86USD 981,139 |
30,796 -90.6% | 31.86 | USD 981,139 | |
| 2023-03-20 | 2023-03-16 | PS Planned sale |
Co-Chief Executive Officer Executive Director |
3,924
-0.1%
32.45USD 127,315 |
3,924 -0.1% | 32.45 | USD 127,315 | |
| 2023-03-20 | 2023-03-16 | PS Planned sale |
Co-Chief Executive Officer Executive Director |
96,076
-3.3%
31.84USD 3,059,021 |
96,076 -3.3% | 31.84 | USD 3,059,021 | |
| 2023-03-20 | 2023-03-16 | B Purchase | Non-Executive Director |
1,000
+inf%
31.99USD 31,990 |
1,000 +inf% | 31.99 | USD 31,990 | |
| 2023-03-17 | 2023-03-16 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
9,122
-0.1%
32.55USD 296,921 |
9,122 -0.1% | 32.55 | USD 296,921 | |
| 2023-03-16 | 2023-03-15 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
41,066
-0.6%
33.68USD 1,383,103 |
41,066 -0.6% | 33.68 | USD 1,383,103 | |
| 2023-03-16 | 2023-03-15 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
108,934
-1.5%
33.12USD 3,607,894 |
108,934 -1.5% | 33.12 | USD 3,607,894 | |
| 2023-03-16 | 2023-03-14 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
70,714
-0.9%
34.54USD 2,442,462 |
70,714 -0.9% | 34.54 | USD 2,442,462 | |
| 2023-03-06 | 2023-03-02 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
50,000
-0.7%
33.75USD 1,687,500 |
50,000 -0.7% | 33.75 | USD 1,687,500 | |
| 2023-02-28 | 2023-02-24 | PS Planned sale |
Chief Legal Officer Officer |
3,586
-8.7%
34.49USD 123,672 |
3,586 -8.7% | 34.49 | USD 123,672 | |
| 2023-02-24 | 2023-02-23 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
1,111
-0.0%
36.24USD 40,263 |
1,111 -0.0% | 36.24 | USD 40,263 | |
| 2023-02-24 | 2023-02-23 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
48,889
-0.6%
35.55USD 1,738,004 |
48,889 -0.6% | 35.55 | USD 1,738,004 | |
| 2023-02-28 | 2023-02-22 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
2,112
-0.0%
35.34USD 74,638 |
2,112 -0.0% | 35.34 | USD 74,638 | |
| 2023-02-28 | 2023-02-22 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
47,888
-0.6%
34.70USD 1,661,714 |
47,888 -0.6% | 34.70 | USD 1,661,714 | |
| 2023-02-24 | 2023-02-22 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
10,084
-0.1%
36.34USD 366,453 |
10,084 -0.1% | 36.34 | USD 366,453 | |
| 2023-02-24 | 2023-02-22 | S Sale |
Morningside Venture Investments Ltd Large shareholder |
39,916
-0.5%
35.91USD 1,433,384 |
39,916 -0.5% | 35.91 | USD 1,433,384 | |
| 2022-09-09 | 2022-09-09 | S Sale | Large shareholder |
3,142
-0.2%
31.44USD 98,792 |
3,142 -0.2% | 31.44 | USD 98,792 | |
| 2022-09-09 | 2022-09-09 | S Sale | Large shareholder |
73,886
-3.8%
30.90USD 2,282,804 |
73,886 -3.8% | 30.90 | USD 2,282,804 | |
| 2022-09-09 | 2022-09-09 | S Sale | Large shareholder |
147,502
-7.1%
29.87USD 4,405,545 |
147,502 -7.1% | 29.87 | USD 4,405,545 | |
| 2022-09-09 | 2022-09-09 | S Sale | Large shareholder |
6,654
-0.2%
31.44USD 209,218 |
6,654 -0.2% | 31.44 | USD 209,218 | |
| 2022-09-09 | 2022-09-09 | S Sale | Large shareholder |
156,463
-3.8%
30.90USD 4,834,128 |
156,463 -3.8% | 30.90 | USD 4,834,128 |